PFAS Chemicals Found in Firefighting Foam May Increase Hypertension Risks: Study
A new study links PFAS chemical exposure to an increased risk of hypertension in women.
A new study links PFAS chemical exposure to an increased risk of hypertension in women.
Heart disease and hypertension may be contributing to rising rates of pregnancy complications in the U.S., according to the findings of a new report.
Hypertensive disorders among pregnant women in the U.S. is increasing, with hypertension-related complications linked to a third of all U.S. pregnancy deaths, according to the CDC.
Pfizer is recalling five lots of Accupril, a hypertension drug, due to the risk of nitrosamine contamination and long-term cancer risk.
Treating high blood pressure in pregnant women before it developed into severe hypertension resulted in better maternal outcomes, according to the findings of a new study.
The CDC has launched a new campaign to fight a climbing maternal mortality rate by urging health care providers to pay more attention to pregnant women's health concerns.
Pfizer is recalling several lots of Accuretic hypertension drugs due to the presence of potentially cancer-causing chemicals.
Two former district judges have been appointed as valsartan settlement special masters to help bring about a resolution to the litigation.
Canadian health regulators have announced an Accuretic recall, indicating the Pfizer hypertension drug contains levels of cancer-causing chemicals above the acceptable amounts.
Valsartan and similar hypertension drugs may carry an increased risk of cancer with long-term use, according to the findings of a new study.